2Oziegler TR. Glutamine supplementation in bone marrow transplantation[J]. Br J Nutr,2002,87(Suppl 1) :9 - 15.
3Schnitzler M, Hasskarl J, Egger M, et al. Successful treatment of severe acute intestinal graft versus host resistant to systemic and topical steroids with alemtuzumab[J]. Biol Blood Marrow Transplant, 2009,15(8) : 910 - 918.
4Thompson B, Salzman D, Steinhauer J, et al. Prospective endoscopic evaluation for gastrointestinal graft - versushost diseaset Determination of the best diagnostic approach[J]. Bone Marrow Transplant,2006,38(5) :371 - 376.
二级参考文献25
1Rachamim N, Gan J, Segall H, et al.Tolerance indirection by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation,1998,65:1386-1393.
2Ringhoffer M,Wesneth M,Harsdorf SV,et al.CD34 + cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation:clinical results in 102 patients. Br J Haematol,2004,126:527-535.
3Conget PA,Minguell JJ.Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells.J Cell Physiol,1999,181: 67-73.
4Potian JA,Ahmeti E,Ramkissoon S,et al.Veto-like activity of mesenchymal stem cells (MSC) and the concentration of interferon-gamma in the microenvironment are important parameters to offset the allogeneic effects of MSC. Blood, 2002,100: 524a.
5Krampera M,Glennie S,Dyson J,et al.Bone marrow mesenehymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood, 2003, 101:3722-3729.
6Lazarus H,Curtin P,Devine S,et al.Role of mesenchymal stem cells in allogeneic transplantation: early phase I clinical results.Blood, 2000,96,392a.
7Lee ST, Jang JH, Cheong JW, et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002,118 : 1128-1131.
8Perruccio K,Tosti A,Posati S,et al.Transfer of functional immune responses to aspergillus and CMV after haploidentical hematopoietic transplantation. Blood, 2000.96: 2383a.
